Background and Aims: This prospective, randomized, double blind study was undertaken to establish the effect of addition of fentanyl or dexmedetomidine, as an adjunct to epidural ropivacaine for eswl.
Materials and Methods: Ninety ASA (American Society of Anesthesiologists) class I and II patients undergoing eswl were enrolled to receive either saline (Group RS) or fentanyl (Group RF) or dexmedetomidine (Group RD) along with epidural ropivacaine for anesthesia. All the study subjects received an epidural anesthesia with 10ml of 0.5% ropivavacaine along with either saline 2ml (Group RS) or fentanyl 1mcg/kg (Group RF) or dexmedetomidine 1.0 μg/kg (Group RD). The onset of motor and sensory block, duration of block, hemodynamic parameters, and adverse events were monitored.
Results: Analgesia in the postoperative period was better in Group RD, together with duration of sensory and motor blockade. However incidence of sedation was more in the RD group.
Conclusion: Hence, addition of Dexmedetomidine to epidural ropivacaine can be advantageous with respect to early onset of both sensory and motor block and increased duration of motor and sensory blockade and arousable sedation.
Impact Factor
2022: 6.012
This work is licensed under a